These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 9619779)
1. P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells. Declèves X; Chappey O; Boval B; Niel E; Scherrmann JM Pharm Res; 1998 May; 15(5):712-8. PubMed ID: 9619779 [TBL] [Abstract][Full Text] [Related]
2. Role of P-glycoprotein in colchicine and vinblastine cellular kinetics in an immortalized rat brain microvessel endothelial cell line. El Hafny B; Cano N; Piciotti M; Regina A; Scherrmann JM; Roux F Biochem Pharmacol; 1997 Jun; 53(11):1735-42. PubMed ID: 9264327 [TBL] [Abstract][Full Text] [Related]
3. In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier. Cisternino S; Rousselle C; Debray M; Scherrmann JM Pharm Res; 2004 Aug; 21(8):1382-9. PubMed ID: 15359572 [TBL] [Abstract][Full Text] [Related]
4. Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice. Cisternino S; Rousselle C; Dagenais C; Scherrmann JM Pharm Res; 2001 Feb; 18(2):183-90. PubMed ID: 11405289 [TBL] [Abstract][Full Text] [Related]
5. In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier. Cisternino S; Rousselle C; Debray M; Scherrmann JM Pharm Res; 2003 Oct; 20(10):1607-11. PubMed ID: 14620515 [TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine. Drion N; Lemaire M; Lefauconnier JM; Scherrmann JM J Neurochem; 1996 Oct; 67(4):1688-93. PubMed ID: 8858954 [TBL] [Abstract][Full Text] [Related]
7. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine. Ogihara T; Kamiya M; Ozawa M; Fujita T; Yamamoto A; Yamashita S; Ohnishi S; Isomura Y Drug Metab Pharmacokinet; 2006 Jun; 21(3):238-44. PubMed ID: 16858128 [TBL] [Abstract][Full Text] [Related]
8. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport. Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095 [TBL] [Abstract][Full Text] [Related]
9. Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier. Matsuzaki J; Yamamoto C; Miyama T; Takanaga H; Matsuo H; Ishizuka H; Kawahara Y; Kuwano M; Naito M; Tsuruo T; Sawada Y Biopharm Drug Dispos; 1999 Mar; 20(2):85-90. PubMed ID: 10206323 [TBL] [Abstract][Full Text] [Related]
10. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein. Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401 [TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Pouliot JF; L'Heureux F; Liu Z; Prichard RK; Georges E Biochem Pharmacol; 1997 Jan; 53(1):17-25. PubMed ID: 8960059 [TBL] [Abstract][Full Text] [Related]
12. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. Regina A; Koman A; Piciotti M; El Hafny B; Center MS; Bergmann R; Couraud PO; Roux F J Neurochem; 1998 Aug; 71(2):705-15. PubMed ID: 9681461 [TBL] [Abstract][Full Text] [Related]
13. Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter. Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P Pharm Res; 1998 Jul; 15(7):1001-6. PubMed ID: 9688051 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. Takanaga H; Ohnishi A; Matsuo H; Sawada Y Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810 [TBL] [Abstract][Full Text] [Related]
15. Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3. Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport. Schlemmer SR; Sirotnak FM J Biol Chem; 1994 Dec; 269(49):31059-66. PubMed ID: 7983045 [TBL] [Abstract][Full Text] [Related]
16. Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system. Nakayama A; Saitoh H; Oda M; Takada M; Aungst BJ Eur J Pharm Sci; 2000 Oct; 11(4):317-24. PubMed ID: 11033075 [TBL] [Abstract][Full Text] [Related]
17. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors. Profit L; Eagling VA; Back DJ AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562 [TBL] [Abstract][Full Text] [Related]
18. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model. Garrigos M; Mir LM; Orlowski S Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038 [TBL] [Abstract][Full Text] [Related]
19. The MDR1 (P-glycoprotein) and MRP (P-190) transporters do not play a major role in the intrinsic multiple drug resistance of Jurkat T lymphocytes. Martel J; Payet MD; Dupuis G Leuk Res; 1997; 21(11-12):1077-86. PubMed ID: 9444942 [TBL] [Abstract][Full Text] [Related]
20. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein. Ambudkar SV; Cardarelli CO; Pashinsky I; Stein WD J Biol Chem; 1997 Aug; 272(34):21160-6. PubMed ID: 9261121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]